8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine - CAS 1353387-21-9
Catalog: |
BB008144 |
Product Name: |
8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine |
CAS: |
1353387-21-9 |
Synonyms: |
8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine; 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine |
IUPAC Name: | 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine |
Description: | 8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine (CAS# 1353387-21-9 ) is a useful research chemical. |
Molecular Weight: | 244.101 |
Molecular Formula: | C13H17BN2O2 |
Canonical SMILES: | B1(OC(C(O1)(C)C)(C)C)C2=CC=CN3C2=NC=C3 |
InChI: | InChI=1S/C13H17BN2O2/c1-12(2)13(3,4)18-14(17-12)10-6-5-8-16-9-7-15-11(10)16/h5-9H,1-4H3 |
InChI Key: | ZONLLDIMAJHMLM-UHFFFAOYSA-N |
Publication Number | Title | Priority Date |
US-2020031835-A1 | Fused pyrazine derivatives as a2a / a2b inhibitors | 20180705 |
TW-202012409-A | Fused pyrazine derivatives as A2A/A2B inhibitors | 20180705 |
BR-112021000075-A2 | PIRAZINE DERIVATIVES MELTED AS A2A / A2B INHIBITORS | 20180705 |
CN-113166153-A | Fused pyrazine derivatives as A2A/A2B inhibitors | 20180705 |
Complexity: | 319 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 244.138308 |
Formal Charge: | 0 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 244.138308 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 35.8 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS